ATC | B/G | Ingredients | code | Registration Nb | Name | Dosage | Presentation | Form | Route | Agent | Laboratory | Country | Price | Pharmacist Margin | Stratum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
L04AA23 | BioTech | Natalizumab - 300mg/15ml | 10731 | 98820/1 | TYSABRI | 300mg/15ml | 1 x 15ml | Injectable concentrated solution | Infusion | Mersaco | Biogen Netherlands BV | The Netherlands | 126,830,594 L.L | 2.44 | E2 | Biogen Netherlands BV | The Netherlands | 2/5/2024 | 0 |